---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-092262"
form_type: "8-K"
ticker: "CYH"
cik: "0001108109"
company_name: "COMMUNITY HEALTH SYSTEMS INC"
filed_at: "2025-07-01T23:59:59+00:00"
generated_at: "2026-05-18T09:54:11.137323+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CHS completes sale of 80% stake in Cedar Park Regional Medical Center to Ascension for $436M

## Summary
- Cash proceeds of $436M (subject to post-close adjustment) from divestiture of Joint Venture interest in Texas hospital.
- Transaction closed June 30, 2025; Ascension Health previously held minority and now owns 100%.
- Pro forma gain on sale of $143M pre-tax ($93M after-tax) recorded in financial statements.
- Divestiture reduces annual net operating revenues by ~$196M; not treated as discontinued operations.
- CHS distributed ~$23M to buyer for amounts owed to the Joint Venture at closing.

## SEC filing metadata
- accession: 0000950170-25-092262
- form_type: 8-K
- ticker: CYH
- cik: 0001108109
- company_name: COMMUNITY HEALTH SYSTEMS INC
- filed_at: 2025-07-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 9.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1108109/000095017025092262/0000950170-25-092262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1108109/000095017025092262/cyh-20250630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-092262
- JSON: https://secwatch.observer/filing/0000950170-25-092262.json
- Plain text: https://secwatch.observer/filing/0000950170-25-092262.txt

## Source-grounded claims
- claim_id: 8c4a7d73d600c2b78ee1355e5ba33159342c15fc
  claim: COMMUNITY HEALTH SYSTEMS INC completed a disposition involving subsidiaries of Ascension Health for $436 million in cash (closed 2025-06-30).
  evidence_excerpt: to the CHS Selling Entities in connection with the Transaction at closing on June 30, 2025, after giving effect to estimated working capital and purchase price adjustments, was $436 million in cash (subject to a post-closing working capital adjustment). In addition, contemporaneous with the closing of the Transaction, in connection with the balance of certain
  evidence_url: https://www.sec.gov/Archives/edgar/data/1108109/000095017025092262/0000950170-25-092262-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
